Pharma Veterans

Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1312 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ivan Samkov Preamble This post is based on a McKinsey article. The core McKinsey source is Bob Li's August 31, 2026 conversation, which outlines the MARS approach around next-generation evidence generation, community education, cancer networks, and international acceleration/collaboration. The wider cancer-burden figures and prevention/early-detection context come from WHO and IARC. Link at the end. Can We Eliminate Cancer? The Real Revolution May Be Access, Not Discovery Cancer has long been portrayed as an enemy that science must defeat through better drugs, better diagnostics and better technology. And there is good reason for th...

Gender Gap in Digital Access – Asrar Qureshi’s Blog Post 1163 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1163 for Pharma Veterans. Pharma    Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Anurag Jamwal Credit: Jhovan Morales Credit: Khezez Credit: RDNE Stock Project Preamble This post is based on Development Aid September report on this subject. Why Access to Technology for Women Must Become a Global Priority In September 2025, DevelopmentAid published a report that laid bare a harsh reality: in many developing countries, women remain far behind men in access to digital technology. They are 19% less likely to use mobile internet than men, and the growth in women working in ICT specialist roles has barely budged; only about 1% increase over a decade. These numbers aren’t just numbers; they represent human lives constrained b...